85404-48-4 Usage
General Description
(-)-Haplomyrfolin is a natural chemical compound isolated from the fruiting bodies of the fungus Hapalopilus myceliosus. It is a sesquiterpene lactone with a unique tricyclic structure and possesses an array of biological activities. Studies have shown that (-)-Haplomyrfolin exhibits strong anti-inflammatory and antitumor properties, making it a potential candidate for the development of new drugs for the treatment of cancer and other inflammatory diseases. Additionally, it has also demonstrated significant antifungal activity against various pathogenic fungi. (-)-Haplomyrfolin has therefore attracted attention from the scientific community as a promising natural product with potential therapeutic applications.
Check Digit Verification of cas no
The CAS Registry Mumber 85404-48-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,5,4,0 and 4 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 85404-48:
(7*8)+(6*5)+(5*4)+(4*0)+(3*4)+(2*4)+(1*8)=134
134 % 10 = 4
So 85404-48-4 is a valid CAS Registry Number.
85404-48-4Relevant articles and documents
Modular synthesis and biological investigation of 5-hydroxymethyl dibenzyl butyrolactones and related lignans
Davidson, Samuel J.,Pilkington, Lisa I.,Dempsey-Hibbert, Nina C.,El-Mohtadi, Mohamed,Tang, Shiying,Wainwright, Thomas,Whitehead, Kathryn A.,Barker, David
, (2018/11/30)
Dibenzyl butyrolactone lignans are well known for their excellent biological properties, particularly for their notable anti-proliferative activities. Herein we report a novel, efficient, convergent synthesis of dibenzyl butyrolactone lignans utilizing the acyl-Claisen rearrangement to stereoselectively prepare a key intermediate. The reported synthetic route enables the modification of these lignans to give rise to 5-hydroxymethyl derivatives of these lignans. The biological activities of these analogues were assessed, with derivatives showing an excellent cytotoxic profile which resulted in programmed cell death of Jurkat T-leukemia cells with less than 2% of the incubated cells entering a necrotic cell death pathway.